In today’s competitive landscape, the successful launch of a biopharmaceutical involves a complex web of changing dynamics across R&D, regulatory, market access and marketing and sales.
For companies launching their first biopharma product, the pressure to deliver a successful product launch is extremely high. Nearly 66% of all drug launches fail to meet pre-launch sales expectations, according to a study conducted by McKinsey.
It is important to approach the launch of a product with a holistic view that covers the entire lifecycle of a product — from discovery, to development and commercialization, all the way through to patient adherence.
In this guide, we’ll explore steps that biopharma companies can take when launching a product to reduce their risks, avoid pitfalls and increase their chances for success across the entire biopharmaceutical lifecycle.